RAND outlines the potential impacts of a drop in demand for Afghan opiates, urging the international community to monitor the market and invest in rural development.
PRI and IDPC detail how policymakers and practitioners in the criminal legal system can reduce the imprisonment of women for drug-related offences in line with international standards.
Christopher Hallam (GDPO) argues for increased support toward heroin-assisted treatment (HAT) by national governments and international bodies, including the INCB.
SSDP considers that the 'drugs cost lives' narrative, although well-meaning, is stigmatising and harmful, and fuels damaging approaches based on prohibition, punishment and criminalisation.
Rêgo et al. argue that, despite the positive progress enabled by the Portuguese model, its limited ambitions, lack of update, and regressions toward punitive responses have severely undermined its potential.
Kvamme et al. suggest that a significant proportion of Danish users of cannabis as medicine are motivated by a desire to alleviate their ailments whilst minimising the negative side effects that they associate with legal prescription drugs.
EMCDDA explores the epidemiology of drug-related health problems in prisons, discussing available harm reduction measures and persistent challenges in these settings.
Grisaffi et al. argue that the successes of coca regulation in Bolivia could be replicated in Peru, as long as efforts centre community empowerment and participation.
